Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Formulation & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1:
1.9.2. Objective 2:
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Demand for Transcriptomics in Cancer Personalized/Precision Medicine
3.2.1.2. Rising Diagnostic Utility Of Transcriptomics Technologies
3.2.1.3. Advent of Novel Approaches for Understanding Gene Expression at RNA Level
3.2.2. Market Restraint Analysis
3.2.2.1. Higher Cost of Research & Developments
3.2.2.2. High Costs Associated With Analysis Platforms
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. RNA Analysis Market: Product Movement Analysis
4.2. Instruments
4.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.3. Kits & Reagents
4.3.1. Kits & Reagents Market, 2018 - 2030 (USD Million)
4.3.2. miRNA & siRNA
4.3.2.1. miRNA & siRNA Market, 2018 - 2030 (USD Million)
4.3.3. Reverse Transcriptases & RT-PCR
4.3.3.1. Reverse Transcriptases & RT-PCR Market, 2018 - 2030 (USD Million)
4.3.4. RNA Extraction & Purification
4.3.4.1. RNA Extraction & Purification Market, 2018 - 2030 (USD Million)
4.3.5. RNA Interference
4.3.5.1. RNA Interference Market, 2018 - 2030 (USD Million)
4.3.6. Others
4.3.6.1. Other Kits & Reagents Market, 2018 - 2030 (USD Million)
4.4. Services
4.4.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. Technology Business Analysis
5.1. RNA Analysis Market: Technology Movement Analysis
5.2. Real Time-PCR (qPCR)
5.2.1. Real Time-PCR (qPCR) Market, 2018 - 2030 (USD Million)
5.3. Microarray
5.3.1. Microarray Market, 2018 - 2030 (USD Million)
5.4. Sequencing
5.4.1. Sequencing Market, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Other Technologies Market, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. RNA Analysis Market: Application Movement Analysis
6.2. Construction of RNA Expression Atlas
6.2.1. Construction of RNA Expression Atlas Market, 2018 - 2030 (USD Million)
6.3. Epigenetics
6.3.1. Epigenetics Market, 2018 - 2030 (USD Million)
6.4. Infectious Diseases & Pathogenesis
6.4.1. Infectious Diseases & Pathogenesis Market, 2018 - 2030 (USD Million)
6.5. Alternative RNA Splicing
6.5.1. Alternative RNA Splicing Market, 2018 - 2030 (USD Million)
6.6. RNA Structure & Molecular Dynamics
6.6.1. RNA Structure & Molecular Dynamics Market, 2018 - 2030 (USD Million)
6.7. Development & Delivery of RNA Therapeutics
6.7.1. Development & Delivery of RNA Therapeutics Market, 2018 - 2030 (USD Million)
6.8. Others
6.8.1. Other Applications Market, 2018 - 2030 (USD Million)
Chapter 7. End-Use Business Analysis
7.1. Government Institutes & Academic Centers
7.1.1. Government Institutes & Academic Centers Market, 2018 - 2030 (USD Million)
7.2. Pharmaceutical & Biotechnology Companies
7.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
7.3. Hospitals & Clinics
7.3.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
7.4. Contract Research Organizations (CROs)
7.4.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. RNA Analysis Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. North America RNA Analysis Market, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Target Disease Prevalence
8.2.2.3. Competitive Scenario
8.2.2.4. U.S. RNA Analysis Market, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Canada RNA Analysis Market, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Target Disease Prevalence
8.3.2.3. Competitive Scenario
8.3.2.4. UK RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Target Disease Prevalence
8.3.3.3. Competitive Scenario
8.3.3.4. Germany RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Target Disease Prevalence
8.3.4.3. Competitive Scenario
8.3.4.4. France RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Target Disease Prevalence
8.3.5.3. Competitive Scenario
8.3.5.4. Italy RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Target Disease Prevalence
8.3.6.3. Competitive Scenario
8.3.6.4. Spain RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Target Disease Prevalence
8.3.7.3. Competitive Scenario
8.3.7.4. Denmark RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Target Disease Prevalence
8.3.8.3. Competitive Scenario
8.3.8.4. Sweden RNA Analysis Market, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Target Disease Prevalence
8.3.9.3. Competitive Scenario
8.3.9.4. Norway RNA Analysis Market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific RNA Analysis Market, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Target Disease Prevalence
8.4.2.3. Competitive Scenario
8.4.2.4. Japan RNA Analysis Market, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Competitive Scenario
8.4.3.4. China RNA Analysis Market, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Competitive Scenario
8.4.4.4. India RNA Analysis Market, 2018 - 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Target Disease Prevalence
8.4.5.3. Competitive Scenario
8.4.5.4. Australia RNA Analysis Market, 2018 - 2030 (USD Million)
8.4.6. Thailand
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Thailand RNA Analysis Market, 2018 - 2030 (USD Million)
8.4.7. South Korea
8.4.7.1. Key Country Dynamics
8.4.7.2. Target Disease Prevalence
8.4.7.3. Competitive Scenario
8.4.7.4. South Korea RNA Analysis Market, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America RNA Analysis Market, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Target Disease Prevalence
8.5.2.3. Competitive Scenario
8.5.2.4. Brazil RNA Analysis Market, 2018 - 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Competitive Scenario
8.5.3.4. Mexico RNA Analysis Market, 2018 - 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Competitive Scenario
8.5.4.4. Argentina RNA Analysis Market, 2018 - 2030 (USD Million)
8.6. MEA
8.6.1. MEA RNA Analysis Market, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Target Disease Prevalence
8.6.2.3. Competitive Scenario
8.6.2.4. South Africa RNA Analysis Market, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Competitive Scenario
8.6.3.4. Saudi Arabia RNA Analysis Market, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Competitive Scenario
8.6.4.4. UAE RNA Analysis Market, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Competitive Scenario
8.6.5.4. Kuwait RNA Analysis Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. Agilent Technologies, Inc
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. F. Hoffmann-La Roche AG
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Illumina, Inc.
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. QIAGEN
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Thermo Fisher Scientific, Inc.
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Eurofins Scientific
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Merck KGaA
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Bio-Rad Laboratories, Inc.
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Pacific Bioscience of California, Inc.;
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Affymetrix, Inc.
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. Danaher
9.4.11.1. Overview
9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.11.3. Product Benchmarking
9.4.11.4. Strategic Initiatives
9.4.12. Promega
9.4.12.1. Overview
9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.12.3. Product Benchmarking
9.4.12.4. Strategic Initiatives
List of Tables
Table 1: List of secondary sources
Table 2: Global RNA analysis market, by product, 2018-2030 (USD Million)
Table 3: Global RNA analysis market, by technology, 2018-2030 (USD Million)
Table 4: Global RNA analysis market, by application, 2018-2030 (USD Million)
Table 5: Global RNA analysis market, by end-use, 2018-2030 (USD Million)
Table 6: Global RNA analysis market, by region, 2018-2030 (USD Million)
Table 7: North America RNA analysis market by product, 2018-2030 (USD Million)
Table 8: North America RNA analysis market by technology, 2018-2030 (USD Million)
Table 9: North America RNA analysis market by application, 2018-2030 (USD Million)
Table 10: North America RNA analysis market by end-use, 2018-2030 (USD Million)
Table 11: U.S. RNA analysis market by product, 2018-2030 (USD Million)
Table 12: U.S. RNA analysis market by technology, 2018-2030 (USD Million)
Table 13: U.S. RNA analysis market by application, 2018-2030 (USD Million)
Table 14: U.S. RNA analysis market by end-use, 2018-2030 (USD Million)
Table 15: Canada RNA analysis market by product, 2018-2030 (USD Million)
Table 16: Canada RNA analysis market by technology, 2018-2030 (USD Million)
Table 17: Canada RNA analysis market by application, 2018-2030 (USD Million)
Table 18: Canada RNA analysis market by end-use, 2018-2030 (USD Million)
Table 19: Europe RNA analysis market by product, 2018-2030 (USD Million)
Table 20: Europe RNA analysis market by technology, 2018-2030 (USD Million)
Table 21: Europe RNA analysis market by application, 2018-2030 (USD Million)
Table 22: Europe RNA analysis market by end-use, 2018-2030 (USD Million)
Table 23: Germany RNA analysis market by product, 2018-2030 (USD Million)
Table 24: Germany RNA analysis market by technology, 2018-2030 (USD Million)
Table 25: Germany RNA analysis market by application, 2018-2030 (USD Million)
Table 26: Germany RNA analysis market by end-use, 2018-2030 (USD Million)
Table 27: U.K. RNA analysis market by product, 2018-2030 (USD Million)
Table 28: U.K. RNA analysis market by technology, 2018-2030 (USD Million)
Table 29: U.K. RNA analysis market by application, 2018-2030 (USD Million)
Table 30: U.K. RNA analysis market by end-use, 2018-2030 (USD Million)
Table 31: France RNA analysis market by product, 2018-2030 (USD Million)
Table 32: France RNA analysis market by technology, 2018-2030 (USD Million)
Table 33: France RNA analysis market by application, 2018-2030 (USD Million)
Table 34: France RNA analysis market by end-use, 2018-2030 (USD Million)
Table 35: Italy RNA analysis market by product, 2018-2030 (USD Million)
Table 36: Italy RNA analysis market by technology, 2018-2030 (USD Million)
Table 37: Italy RNA analysis market by application, 2018-2030 (USD Million)
Table 38: Italy RNA analysis market by end-use, 2018-2030 (USD Million)
Table 39: Spain RNA analysis market by product, 2018-2030 (USD Million)
Table 40: Spain RNA analysis market by technology, 2018-2030 (USD Million)
Table 41: Spain RNA analysis market by application, 2018-2030 (USD Million)
Table 42: Spain RNA analysis market by end-use, 2018-2030 (USD Million)
Table 43: Denmark RNA analysis market by product, 2018-2030 (USD Million)
Table 44: Denmark RNA analysis market by technology, 2018-2030 (USD Million)
Table 45: Denmark RNA analysis market by application, 2018-2030 (USD Million)
Table 46: Denmark RNA analysis market by end-use, 2018-2030 (USD Million)
Table 47: Sweden RNA analysis market by product, 2018-2030 (USD Million)
Table 48: Sweden RNA analysis market by technology, 2018-2030 (USD Million)
Table 49: Sweden RNA analysis market by application, 2018-2030 (USD Million)
Table 50: Sweden RNA analysis market by end-use, 2018-2030 (USD Million)
Table 51: Norway RNA analysis market by product, 2018-2030 (USD Million)
Table 52: Norway RNA analysis market by technology, 2018-2030 (USD Million)
Table 53: Norway RNA analysis market by application, 2018-2030 (USD Million)
Table 54: Norway RNA analysis market by end-use, 2018-2030 (USD Million)
Table 55: Asia Pacific RNA analysis market by product, 2018-2030 (USD Million)
Table 56: Asia Pacific RNA analysis market by technology, 2018-2030 (USD Million)
Table 57: Asia Pacific RNA analysis market by application, 2018-2030 (USD Million)
Table 58: Asia Pacific RNA analysis market by end-use, 2018-2030 (USD Million)
Table 59: China RNA analysis market by product, 2018-2030 (USD Million)
Table 60: China RNA analysis market by technology, 2018-2030 (USD Million)
Table 61: China RNA analysis market by application, 2018-2030 (USD Million)
Table 62: China RNA analysis market by end-use, 2018-2030 (USD Million)
Table 63: Japan RNA analysis market by product, 2018-2030 (USD Million)
Table 64: Japan RNA analysis market by technology, 2018-2030 (USD Million)
Table 65: Japan RNA analysis market by application, 2018-2030 (USD Million)
Table 66: Japan RNA analysis market by end-use, 2018-2030 (USD Million)
Table 67: India RNA analysis market by product, 2018-2030 (USD Million)
Table 68: India RNA analysis market by technology, 2018-2030 (USD Million)
Table 69: India RNA analysis market by application, 2018-2030 (USD Million)
Table 70: India RNA analysis market by end-use, 2018-2030 (USD Million)
Table 71: Australia RNA analysis market by product, 2018-2030 (USD Million)
Table 72: Australia RNA analysis market by technology, 2018-2030 (USD Million)
Table 73: Australia RNA analysis market by application, 2018-2030 (USD Million)
Table 74: Australia RNA analysis market by end-use, 2018-2030 (USD Million)
Table 75: Thailand RNA analysis market by product, 2018-2030 (USD Million)
Table 76: Thailand RNA analysis market by technology, 2018-2030 (USD Million)
Table 77: Thailand RNA analysis market by application, 2018-2030 (USD Million)
Table 78: Thailand RNA analysis market by end-use, 2018-2030 (USD Million)
Table 79: South Korea RNA analysis market by product, 2018-2030 (USD Million)
Table 80: South Korea RNA analysis market by technology, 2018-2030 (USD Million)
Table 81: South Korea RNA analysis market by application, 2018-2030 (USD Million)
Table 82: South Korea RNA analysis market by end-use, 2018-2030 (USD Million)
Table 83: Latin America RNA analysis market by product, 2018-2030 (USD Million)
Table 84: Latin America RNA analysis market by technology, 2018-2030 (USD Million)
Table 85: Latin America RNA analysis market by application, 2018-2030 (USD Million)
Table 86: Latin America RNA analysis market by end-use, 2018-2030 (USD Million)
Table 87: Brazil RNA analysis market by product, 2018-2030 (USD Million)
Table 88: Brazil RNA analysis market by technology, 2018-2030 (USD Million)
Table 89: Brazil RNA analysis market by application, 2018-2030 (USD Million)
Table 90: Brazil RNA analysis market by end-use, 2018-2030 (USD Million)
Table 91: Mexico RNA analysis market by product, 2018-2030 (USD Million)
Table 92: Mexico RNA analysis market by technology, 2018-2030 (USD Million)
Table 93: Mexico RNA analysis market by application, 2018-2030 (USD Million)
Table 94: Mexico RNA analysis market by end-use, 2018-2030 (USD Million)
Table 95: Argentina RNA analysis market by product, 2018-2030 (USD Million)
Table 96: Argentina RNA analysis market by technology, 2018-2030 (USD Million)
Table 97: Argentina RNA analysis market by application, 2018-2030 (USD Million)
Table 98: Argentina RNA analysis market by end-use, 2018-2030 (USD Million)
Table 99: MEA RNA analysis market by product, 2018-2030 (USD Million)
Table 100: MEA RNA analysis market by technology, 2018-2030 (USD Million)
Table 101: MEA RNA analysis market by application, 2018-2030 (USD Million)
Table 102: MEA RNA analysis market by end-use, 2018-2030 (USD Million)
Table 103: South Africa RNA analysis market by product, 2018-2030 (USD Million)
Table 104: South Africa RNA analysis market by technology, 2018-2030 (USD Million)
Table 105: South Africa RNA analysis market by application, 2018-2030 (USD Million)
Table 106: South Africa RNA analysis market by end-use, 2018-2030 (USD Million)
Table 107: Saudi Arabia RNA analysis market by product, 2018-2030 (USD Million)
Table 108: Saudi Arabia RNA analysis market by technology, 2018-2030 (USD Million)
Table 109: Saudi Arabia RNA analysis market by application, 2018-2030 (USD Million)
Table 110: Saudi Arabia RNA analysis market by end-use, 2018-2030 (USD Million)
Table 111: UAE RNA analysis market by product, 2018-2030 (USD Million)
Table 112: UAE RNA analysis market by technology, 2018-2030 (USD Million)
Table 113: UAE RNA analysis market by application, 2018-2030 (USD Million)
Table 114: UAE RNA analysis market by end-use, 2018-2030 (USD Million)
Table 115: Kuwait RNA analysis market by product, 2018-2030 (USD Million)
Table 116: Kuwait RNA analysis market by technology, 2018-2030 (USD Million)
Table 117: Kuwait RNA analysis market by application, 2018-2030 (USD Million)
Table 118: Kuwait RNA analysis market by end-use, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market research process
Fig. 2: Information procurement
Fig. 3: Primary research pattern
Fig. 4: Market research approaches
Fig. 5: Value chain-based sizing & forecasting
Fig. 6: Market formulation & validation
Fig. 7: RNA analysis market segmentation
Fig. 8: Market snapshot, 2022
Fig. 9: Market trends & outlook
Fig. 10: Market driver relevance analysis (current & future impact)
Fig. 11: Market restraint relevance analysis (current & future impact)
Fig. 12: PESTEL analysis
Fig. 13: Porter’s five forces analysis
Fig. 14: RNA analysis market: Products outlook and key takeaways
Fig. 15: RNA analysis market: Product movement analysis
Fig. 16: Instruments market estimates and forecast, 2018-2030 (USD Million)
Fig. 17: Kits & reagents market estimates and forecast, 2018-2030 (USD Million)
Fig. 18: miRNA and siRNA market estimates and forecast, 2018-2030 (USD Million)
Fig. 19: Reverse transcriptase & RT-PCR market estimates and forecast, 2018-2030 (USD Million)
Fig. 20: RNA extraction & purification market estimates and forecast, 2018-2030 (USD Million)
Fig. 21: RNA interference market estimates and forecast, 2018-2030 (USD Million)
Fig. 22: Others kits & reagents market estimates and forecast, 2018-2030 (USD Million)
Fig. 23: Services market estimates and forecast, 2018-2030 (USD Million)
Fig. 24: RNA analysis market: Technology outlook and key takeaways
Fig. 25: RNA analysis market: Technology movement analysis
Fig. 26: Real time-PCR (qPCR) market estimates and forecast, 2018-2030 (USD Million)
Fig. 27: Microarray market estimates and forecast, 2018-2030 (USD Million)
Fig. 28: Sequencing market estimates and forecast, 2018-2030 (USD Million)
Fig. 29: Other technologies market estimates and forecast, 2018-2030 (USD Million)
Fig. 30: RNA analysis market: Application outlook and key takeaways
Fig. 31: RNA analysis Market: Application movement analysis
Fig. 32: Construction of RNA expression atlas market estimates and forecast, 2018-2030 (USD Million)
Fig. 33: Epigenetics market estimates and forecast, 2018-2030 (USD Million)
Fig. 34: Infectious diseases and pathogenesis market estimates and forecast, 2018-2030 (USD Million)
Fig. 35: Alternative RNA splicing market estimates and forecast, 2018-2030 (USD Million)
Fig. 36: RNA structure and molecular dynamics market estimates and forecast, 2018-2030 (USD Million)
Fig. 37: Development and delivery of RNA therapeutics market estimates and forecast, 2018-2030 (USD Million)
Fig. 38: Others applications market estimates and forecast, 2018-2030 (USD Million)
Fig. 39: RNA analysis market: End-use outlook and key takeaways
Fig. 40: RNA analysis market: End-use movement analysis
Fig. 41: Government institutes & academic centers estimates and forecast, 2018-2030 (USD Million)
Fig. 42: Pharmaceutical & biotechnology companies estimates and forecast, 2018-2030 (USD Million)
Fig. 43: Hospitals & clinics estimates and forecast, 2018-2030 (USD Million)
Fig. 44: Contract Research Organizations (CROs) estimates and forecast, 2018-2030 (USD Million)
Fig. 45: RNA analysis market: Regional outlook and key takeaways
Fig. 46: RNA analysis market: Regional movement analysis
Fig. 47: North America market estimates and forecast, 2018-2030 (USD Million)
Fig. 48: U.S. market estimates and forecast, 2018-2030 (USD Million)
Fig. 49: Canada market estimates and forecast, 2018-2030 (USD Million)
Fig. 50: Europe market estimates and forecast, 2018-2030 (USD Million)
Fig. 51: Germany market estimates and forecast, 2018-2030 (USD Million)
Fig. 52: U.K. market estimates and forecast, 2018-2030 (USD Million)
Fig. 53: France market estimates and forecast, 2018-2030 (USD Million)
Fig. 54: Italy market estimates and forecast, 2018-2030 (USD Million)
Fig. 55: Spain market estimates and forecast, 2018-2030 (USD Million)
Fig. 56: Denmark market estimates and forecast, 2018-2030 (USD Million)
Fig. 57: Sweden market estimates and forecast, 2018-2030 (USD Million)
Fig. 58: Norway market estimates and forecast, 2018-2030 (USD Million)
Fig. 59: Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
Fig. 60: Japan market estimates and forecast, 2018-2030 (USD Million)
Fig. 61: China market estimates and forecast, 2018-2030 (USD Million)
Fig. 62: India market estimates and forecast, 2018-2030 (USD Million)
Fig. 63: Australia market estimates and forecast, 2018-2030 (USD Million)
Fig. 64: Thailand market estimates and forecast, 2018-2030 (USD Million)
Fig. 65: South Korea market estimates and forecast, 2018-2030 (USD Million)
Fig. 66: Latin America market estimates and forecast, 2018-2030 (USD Million)
Fig. 67: Brazil market estimates and forecast, 2018-2030 (USD Million)
Fig. 68: Mexico market estimates and forecast, 2018-2030 (USD Million)
Fig. 69: Argentina market estimates and forecast, 2018-2030 (USD Million)
Fig. 70: MEA market estimates and forecast, 2018-2030 (USD Million)
Fig. 71: South Africa market estimates and forecast, 2018-2030 (USD Million)
Fig. 72: Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
Fig. 73: UAE market estimates and forecast, 2018-2030 (USD Million)
Fig. 74: Kuwait market estimates and forecast, 2018-2030 (USD Million)